DAPAGLIFLOZIN AND SAXAGLIPTIN

0 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking DAPAGLIFLOZIN AND SAXAGLIPTIN:

# Side effect Count
See all common reactions for DAPAGLIFLOZIN AND SAXAGLIPTIN

DAPAGLIFLOZIN AND SAXAGLIPTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
See all enriched reactions for DAPAGLIFLOZIN AND SAXAGLIPTIN